Year: 2013
Type: article
Abstract: The development of proteomics technology over the past decade has advanced the identification and validation of new biomarkers.Clinical applications of serum biomarkers will benefit us by being cost-effective and non-invasive, as well as by allowing the simple detection of diseases.Numerous serum biomarkers for lung cancer have been identified and reported in publications.Despite extensive studies, cancer detection via a single marker remains difficult due to the low sensitivity, specificity and reproducibility of the identified lung cancer serum biomarkers.An optimal combination of multiple biomarkers, rather than a single biomarker, should be considered for the development of a lung cancer detection biomarker panel and should be validated with these combinatory markers.This review summarizes the lung cancer biomarkers that have been published within the last five years.
Authors: Jung Mo Ahn, Je Yoel Cho
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2566604112